CenterWatch Webinar Training Pass

Gain Access to Dozens of Web-Based Training Programs For One Low Price!

We can't provide you with more staff members or travel money to get to new training programs. But we can provide expert training for you in ONE place...without ever leaving your office. The Webinar Training Pass gives you year-round unrestricted access to dozens of on-demand training webinars, featuring top clinical trials experts and FDA officials. Need training on a topic? The Training Pass lets you train on your schedule—on the subjects you need most. Webinar Training Pass Gives You:

  1. Training from the best minds and thought leaders in the clinical trials industry.
  2. Wide variety of topics to help you stay in compliance with the FDA.
  3. Instant, on-demand, unlimited access to dozens of archived webinars.
  4. One automatic registration to more than 40 live webinars we'll host during the life of your subscription.

Single-User, One-Year Unlimited Webinar Access for only $597

Don't forget this includes all our archives, PLUS all the new webinars we produce for 12 months, all available on YOUR SCHEDULE!

Purchase 1-year Access

Note: After purchase, you access will be emailed to you within one business day from date of purchase. If you have not received your login information, please contact customer service.

Want training for your entire team? Call (888) 838-5578 or email customerservice@fdanews.com for multi-user pricing to receive deep discounts for 2, 5 or even unlimited users.

Login

Registered User? Login Now

Forgot Your Password? Recover it

Appendix M of the NIH Guidelines

47 minutes

Recorded on Tuesday, June 05, 2018

Description

Clinical research expert Daniel Kavanagh discusses registration and reporting requirements for gene therapy research under the recently revised NIH guidelines. He covers:

  • NIH reporting compliance;
  • The Office of Science Policy registration process; and
  • Progress and safety reporting requirements.

Speaker: Daniel Kavanagh, Senior Director of Biosafety and Gene Therapy, WCG Biosafety

Cutting the Costs of Clinical Trial Subject Recruitment

62 minutes

Recorded on Wednesday, May 30, 2018

Description

Patient recruitment expert Steven Pyffer discusses ways to reach potential research subjects through both tradition and digital avenues. He covers:

  • Insight on the factors that determine the actual outreach cost of a randomized patient;
  • Ways to reduce patient outreach cost; and
  • Improved expectations to patient outreach performance.

Speaker: Steven Pyffer, Senior Director of Patient Outreach, ThreeWire

Managing Safety Reporting for Advanced Therapies

53 minutes

Recorded on Tuesday, May 22, 2018

Description

Pharmacovigilance expert Angela Pitwood looks at compliance challenges for gene therapies and other novel treatments in personalized medicine. She discusses:

  •  Cutting-edge therapies that offer hope for conditions for which there are limited or no therapeutic options now;
  • Development of advanced therapies; and
  • FDA safety reporting requirements, both now and in the future.

Speaker: Angela Pitwood, Vice President of Pharmacovigilance, Vigilare

Clinical Trials and Assessment of Suicidal Ideation and Behavior

60 minutes

Recorded on Tuesday, May 15, 2018

Description

Suicide treatment experts Larry Alphs, Jennifer Giddens and David Sheehan present latest trends and developments in measuring suicidal ideation and behavior. They discuss:

  • Drug development targeting suicidality;
  • What’s new in design and execution of studies of suicidal ideation and behavior;
  • Phenotypes in suicidality; and 
  • Assessments in clinical trials for anti-suicidality treatments

Speakers: Larry Alphs, Therapeutic Area Leader, Ortho-McNeil Janssen; Jennifer Giddens, Co-founder & Co-director, Tampa Center for Research on Suicidality; and David Sheehan, Distinguished University Health Professor Emeritus, University of South Florida College of Medicine